Share Price and Basic Stock Data
Last Updated: December 29, 2025, 12:00 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Tijaria Polypipes Ltd operates in the plastics industry, specifically focusing on pipes and fittings. The company faced significant revenue challenges in recent years, with reported sales declining from ₹149.53 Cr in FY 2019 to merely ₹13.85 Cr in FY 2023. The downward trend continued, with revenue standing at just ₹0.15 Cr for FY 2024 and projected figures indicating no sales for FY 2025. The quarterly sales figures reflect a similar trend, with Jun 2022 sales at ₹9.91 Cr, plummeting to ₹0.04 Cr by Jun 2023 and further declining to ₹0.00 Cr in multiple quarters thereafter. The drastic drop in sales suggests severe operational issues, likely affecting market competitiveness and overall business sustainability.
Profitability and Efficiency Metrics
The profitability metrics for Tijaria Polypipes present a troubling picture, with net profit consistently in the negative territory. For FY 2023, the company recorded a net profit of -₹9.46 Cr, and this negative trajectory continued with net profits of -₹2.92 Cr in FY 2024, and -₹5.43 Cr projected for FY 2025. Operating profit margins also reflected this decline, with an operating profit margin of -30.69% in FY 2023 and worsening to -200% in FY 2024. The interest coverage ratio stood at 1.12x, indicating only a marginal ability to cover interest expenses, while the return on capital employed (ROCE) was negative across multiple periods, emphasizing inefficiency in utilizing capital for generating profits.
Balance Sheet Strength and Financial Ratios
The balance sheet of Tijaria Polypipes reveals significant financial strain. As of Mar 2025, total borrowings amounted to ₹72.40 Cr, against negative reserves of ₹61.79 Cr, reflecting a precarious equity position. The total liabilities were reported at ₹54.48 Cr with total assets standing at ₹54.52 Cr, indicating a very thin margin of asset coverage over liabilities. The price-to-book value ratio was recorded at -0.47x, signaling a market valuation that undervalues the company’s equity. Furthermore, the company’s current ratio of 1.66x suggests that it can cover its short-term liabilities, but the high level of debt compared to equity, with a total debt-to-equity ratio of -2.38x, raises concerns about long-term solvency and financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Tijaria Polypipes indicates a diverse ownership structure. Promoters hold 35.27% of the shares, while the public holds a significant 60.91%, reflecting a diluted control by the promoters. Foreign Institutional Investors (FIIs) have gradually increased their stake from 0% in previous quarters to 3.84%, suggesting some level of regained confidence, although it remains low compared to typical sector levels. Domestic Institutional Investors (DIIs) have no reported stake, which may reflect a lack of institutional interest in the company. The number of shareholders has seen a gradual increase, standing at 11,585 as of Sep 2025, indicating that while there is public interest, the overall investor sentiment remains cautious given the company’s financial challenges.
Outlook, Risks, and Final Insight
The outlook for Tijaria Polypipes appears challenging, primarily due to persistent operational losses and declining revenues. The company’s ability to turn around its performance hinges on addressing its operational inefficiencies and enhancing its market competitiveness. Key risks include the high level of debt relative to equity and the negative reserve situation, which could limit financial flexibility. Additionally, the lack of institutional backing may hinder growth prospects. However, if Tijaria can stabilize its operations and improve profitability, it may attract renewed interest from both institutional and retail investors, potentially setting the stage for recovery. For a successful turnaround, strategic restructuring and a focus on core business operations would be essential.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dutron Polymers Ltd | 67.8 Cr. | 113 | 175/107 | 32.3 | 49.1 | 1.32 % | 12.3 % | 9.68 % | 10.0 |
| Captain Polyplast Ltd | 485 Cr. | 81.0 | 128/58.4 | 24.5 | 28.0 | 0.00 % | 16.1 % | 15.0 % | 2.00 |
| Captain Pipes Ltd | 174 Cr. | 11.3 | 20.5/11.1 | 48.8 | 2.69 | 0.00 % | 17.0 % | 13.5 % | 1.00 |
| Caprihans India Ltd | 127 Cr. | 86.6 | 184/78.1 | 269 | 0.00 % | 0.78 % | 18.9 % | 10.0 | |
| Ashish Polyplast Ltd | 12.2 Cr. | 35.9 | 58.0/30.0 | 20.7 | 0.00 % | 5.09 % | 2.58 % | 10.0 | |
| Industry Average | 5,300.88 Cr | 195.85 | 46.06 | 86.74 | 0.23% | 10.40% | 10.62% | 8.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.09 | 0.00 | 3.84 | 0.04 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.43 | 0.29 | 5.86 | 0.23 | 0.01 | 0.03 | 0.20 | 0.17 | 0.04 | 0.04 | 0.05 | 0.10 | 0.10 |
| Operating Profit | -0.34 | -0.29 | -2.02 | -0.19 | -0.01 | -0.03 | -0.09 | -0.17 | -0.04 | -0.04 | -0.05 | -0.10 | -0.10 |
| OPM % | -377.78% | -52.60% | -475.00% | -81.82% | |||||||||
| Other Income | 0.03 | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 | 0.08 | 0.13 | 0.05 | 0.06 | -3.06 | 0.02 | 0.10 |
| Interest | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Depreciation | 0.83 | 0.83 | 0.80 | 0.68 | 0.69 | 0.69 | 0.70 | 0.58 | 0.94 | 0.76 | 0.03 | 0.19 | 0.19 |
| Profit before tax | -1.17 | -1.10 | -2.79 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 | -0.39 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -1.17 | -1.11 | -2.80 | -0.85 | -0.66 | -0.69 | -0.71 | -0.62 | -0.93 | -0.74 | -3.14 | -0.27 | -0.40 |
| EPS in Rs | -0.41 | -0.39 | -0.98 | -0.30 | -0.23 | -0.24 | -0.25 | -0.22 | -0.32 | -0.26 | -1.10 | -0.09 | -0.14 |
Last Updated: December 28, 2025, 7:34 pm
Below is a detailed analysis of the quarterly data for Tijaria Polypipes Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.10 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.10 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.10 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -0.10 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 0.10 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Jun 2025) to 0.10 Cr., marking an increase of 0.08 Cr..
- For Interest, as of Sep 2025, the value is 0.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Jun 2025) to 0.20 Cr., marking an increase of 0.20 Cr..
- For Depreciation, as of Sep 2025, the value is 0.19 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.19 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.39 Cr.. The value appears to be declining and may need further review. It has decreased from -0.27 Cr. (Jun 2025) to -0.39 Cr., marking a decrease of 0.12 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -0.40 Cr.. The value appears to be declining and may need further review. It has decreased from -0.27 Cr. (Jun 2025) to -0.40 Cr., marking a decrease of 0.13 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.14. The value appears to be declining and may need further review. It has decreased from -0.09 (Jun 2025) to -0.14, marking a decrease of 0.05.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108.57 | 69.11 | 87.03 | 63.54 | 76.34 | 149.53 | 73.39 | 62.46 | 54.88 | 13.85 | 0.15 | 0.00 | 0.00 |
| Expenses | 99.49 | 61.05 | 80.92 | 66.07 | 83.95 | 129.73 | 64.62 | 66.11 | 63.93 | 18.10 | 0.45 | 0.27 | 0.29 |
| Operating Profit | 9.08 | 8.06 | 6.11 | -2.53 | -7.61 | 19.80 | 8.77 | -3.65 | -9.05 | -4.25 | -0.30 | -0.27 | -0.29 |
| OPM % | 8.36% | 11.66% | 7.02% | -3.98% | -9.97% | 13.24% | 11.95% | -5.84% | -16.49% | -30.69% | -200.00% | ||
| Other Income | 0.00 | 5.05 | 0.19 | -1.42 | -1.06 | 0.67 | 0.36 | 0.91 | -0.11 | 0.13 | 0.17 | -2.83 | -2.88 |
| Interest | 8.85 | 8.73 | 9.10 | 7.18 | 7.51 | 7.94 | 6.40 | 6.51 | 8.42 | 2.01 | 0.02 | 0.02 | 0.20 |
| Depreciation | 10.43 | 13.53 | 11.80 | 9.78 | 8.23 | 6.34 | 5.20 | 4.76 | 4.13 | 3.32 | 2.76 | 2.31 | 1.17 |
| Profit before tax | -10.20 | -9.15 | -14.60 | -20.91 | -24.41 | 6.19 | -2.47 | -14.01 | -21.71 | -9.45 | -2.91 | -5.43 | -4.54 |
| Tax % | 5.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -10.80 | -9.15 | -14.60 | -20.92 | -24.41 | 6.19 | -2.46 | -14.01 | -21.70 | -9.46 | -2.92 | -5.43 | -4.55 |
| EPS in Rs | -4.57 | -3.87 | -6.18 | -8.85 | -10.33 | 2.32 | -0.86 | -4.89 | -7.58 | -3.30 | -1.02 | -1.90 | -1.59 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 15.28% | -59.56% | -43.29% | -16.68% | 125.36% | -139.74% | -469.51% | -54.89% | 56.41% | 69.13% | -85.96% |
| Change in YoY Net Profit Growth (%) | 0.00% | -74.84% | 16.28% | 26.61% | 142.04% | -265.10% | -329.77% | 414.62% | 111.29% | 12.73% | -155.09% |
Tijaria Polypipes Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 14% |
| 1 Year: | -52% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 4, 2025, 2:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23.63 | 23.63 | 23.63 | 23.63 | 23.63 | 26.72 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 | 28.63 |
| Reserves | 55.50 | 46.31 | 31.71 | 10.79 | -11.84 | -5.37 | -7.73 | -21.66 | -43.35 | -52.78 | -55.70 | -61.13 | -61.79 |
| Borrowings | 65.58 | 62.07 | 64.63 | 67.23 | 69.90 | 54.12 | 50.76 | 65.88 | 69.15 | 76.36 | 72.41 | 77.40 | 72.40 |
| Other Liabilities | 10.00 | 13.54 | 10.87 | 13.36 | 30.23 | 35.10 | 24.14 | 24.02 | 13.27 | 9.32 | 9.18 | 9.58 | 9.84 |
| Total Liabilities | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 | 49.08 |
| Fixed Assets | 90.33 | 75.67 | 65.41 | 57.71 | 47.13 | 39.19 | 34.52 | 33.56 | 28.79 | 25.31 | 22.55 | 17.12 | 16.74 |
| CWIP | 7.03 | 1.25 | 1.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 57.35 | 68.63 | 64.07 | 57.30 | 64.79 | 71.38 | 61.28 | 63.18 | 38.91 | 36.22 | 31.97 | 37.36 | 32.34 |
| Total Assets | 154.71 | 145.55 | 130.84 | 115.01 | 111.92 | 110.57 | 95.80 | 96.87 | 67.70 | 61.53 | 54.52 | 54.48 | 49.08 |
Below is a detailed analysis of the balance sheet data for Tijaria Polypipes Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 28.63 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 28.63 Cr..
- For Reserves, as of Sep 2025, the value is -61.79 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -61.13 Cr. (Mar 2025) to -61.79 Cr., marking a decline of 0.66 Cr..
- For Borrowings, as of Sep 2025, the value is 72.40 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 77.40 Cr. (Mar 2025) to 72.40 Cr., marking a decrease of 5.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.58 Cr. (Mar 2025) to 9.84 Cr., marking an increase of 0.26 Cr..
- For Total Liabilities, as of Sep 2025, the value is 49.08 Cr.. The value appears to be improving (decreasing). It has decreased from 54.48 Cr. (Mar 2025) to 49.08 Cr., marking a decrease of 5.40 Cr..
- For Fixed Assets, as of Sep 2025, the value is 16.74 Cr.. The value appears to be declining and may need further review. It has decreased from 17.12 Cr. (Mar 2025) to 16.74 Cr., marking a decrease of 0.38 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 32.34 Cr.. The value appears to be declining and may need further review. It has decreased from 37.36 Cr. (Mar 2025) to 32.34 Cr., marking a decrease of 5.02 Cr..
- For Total Assets, as of Sep 2025, the value is 49.08 Cr.. The value appears to be declining and may need further review. It has decreased from 54.48 Cr. (Mar 2025) to 49.08 Cr., marking a decrease of 5.40 Cr..
However, the Borrowings (72.40 Cr.) are higher than the Reserves (-61.79 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -56.50 | -54.01 | -58.52 | -69.76 | -77.51 | -34.32 | -41.99 | -69.53 | -78.20 | -80.61 | -72.71 | -77.67 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93.70 | 167.26 | 103.97 | 152.86 | 163.47 | 136.04 | 198.19 | 218.50 | 167.67 | 659.90 | 60,784.67 | |
| Inventory Days | 71.18 | 190.53 | 168.43 | 147.34 | 85.65 | 29.43 | 100.16 | 109.28 | 39.39 | 11.91 | 997.67 | |
| Days Payable | 31.01 | 85.09 | 46.37 | 71.98 | 161.85 | 116.40 | 175.15 | 114.50 | 72.58 | 167.97 | 16,863.00 | |
| Cash Conversion Cycle | 133.86 | 272.71 | 226.03 | 228.22 | 87.27 | 49.07 | 123.19 | 213.27 | 134.49 | 503.84 | 44,919.33 | |
| Working Capital Days | 13.72 | 67.66 | 15.81 | 57.79 | -31.08 | 34.20 | 80.12 | 153.69 | 67.91 | 324.15 | 30,343.67 | |
| ROCE % | -0.90% | -3.35% | -4.29% | -10.73% | -16.85% | 18.22% | 5.36% | -10.44% | -20.41% | -13.88% | -5.88% | -5.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Diluted EPS (Rs.) | -2.30 | -1.23 | -3.30 | -7.57 | -4.87 |
| Cash EPS (Rs.) | -1.09 | -0.05 | -2.60 | -6.14 | -3.23 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -11.35 | -9.46 | -8.44 | -5.14 | 2.43 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.05 | 4.84 | 19.17 | 21.82 |
| PBDIT / Share (Rs.) | 0.01 | -0.04 | -1.44 | -3.20 | -1.56 |
| PBIT / Share (Rs.) | -0.79 | -1.01 | -2.14 | -4.64 | -3.23 |
| PBT / Share (Rs.) | -0.80 | -1.02 | -3.30 | -7.58 | -4.89 |
| Net Profit / Share (Rs.) | -1.90 | -1.02 | -3.30 | -7.58 | -4.89 |
| PBDIT Margin (%) | 0.00 | -79.03 | -29.67 | -16.67 | -7.16 |
| PBIT Margin (%) | 0.00 | -1940.33 | -44.21 | -24.20 | -14.79 |
| PBT Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Net Profit Margin (%) | 0.00 | -1963.75 | -68.28 | -39.54 | -22.43 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -201.27 |
| Return on Capital Employeed (%) | -6.91 | -7.50 | -14.82 | -30.52 | -13.83 |
| Return On Assets (%) | -9.96 | -5.34 | -15.36 | -32.05 | -14.46 |
| Long Term Debt / Equity (X) | -2.02 | -2.42 | -2.71 | -3.96 | 8.60 |
| Total Debt / Equity (X) | -2.38 | -2.67 | -3.16 | -4.70 | 9.46 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.21 | 0.66 | 0.64 |
| Current Ratio (X) | 1.66 | 1.88 | 1.71 | 1.54 | 2.04 |
| Quick Ratio (X) | 1.64 | 1.86 | 1.69 | 1.30 | 1.55 |
| Inventory Turnover Ratio (X) | 0.00 | 0.10 | 3.43 | 4.94 | 3.54 |
| Interest Coverage Ratio (X) | 1.12 | -6.99 | -1.24 | -1.09 | -0.93 |
| Interest Coverage Ratio (Post Tax) (X) | -128.14 | -171.73 | -1.84 | -1.58 | -1.94 |
| Enterprise Value (Cr.) | 91.12 | 107.14 | 84.52 | 84.89 | 78.81 |
| EV / Net Operating Revenue (X) | 0.00 | 721.44 | 6.10 | 1.55 | 1.26 |
| EV / EBITDA (X) | 4578.83 | -912.86 | -20.57 | -9.27 | -17.60 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 245.76 | 0.90 | 0.33 | 0.28 |
| Price / BV (X) | -0.47 | -1.35 | -0.52 | -1.25 | 2.59 |
| Price / Net Operating Revenue (X) | 0.00 | 250.00 | 0.90 | 0.33 | 0.28 |
| EarningsYield | -0.34 | -0.07 | -0.75 | -1.18 | -0.77 |
After reviewing the key financial ratios for Tijaria Polypipes Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Diluted EPS (Rs.), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 5. It has decreased from -1.23 (Mar 24) to -2.30, marking a decrease of 1.07.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.09. This value is below the healthy minimum of 3. It has decreased from -0.05 (Mar 24) to -1.09, marking a decrease of 1.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.35. It has decreased from -9.46 (Mar 24) to -11.35, marking a decrease of 1.89.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -0.04 (Mar 24) to 0.01, marking an increase of 0.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.79. This value is below the healthy minimum of 0. It has increased from -1.01 (Mar 24) to -0.79, marking an increase of 0.22.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.80. This value is below the healthy minimum of 0. It has increased from -1.02 (Mar 24) to -0.80, marking an increase of 0.22.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.90. This value is below the healthy minimum of 2. It has decreased from -1.02 (Mar 24) to -1.90, marking a decrease of 0.88.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -79.03 (Mar 24) to 0.00, marking an increase of 79.03.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,940.33 (Mar 24) to 0.00, marking an increase of 1,940.33.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -1,963.75 (Mar 24) to 0.00, marking an increase of 1,963.75.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -6.91. This value is below the healthy minimum of 10. It has increased from -7.50 (Mar 24) to -6.91, marking an increase of 0.59.
- For Return On Assets (%), as of Mar 25, the value is -9.96. This value is below the healthy minimum of 5. It has decreased from -5.34 (Mar 24) to -9.96, marking a decrease of 4.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -2.02. This value is below the healthy minimum of 0.2. It has increased from -2.42 (Mar 24) to -2.02, marking an increase of 0.40.
- For Total Debt / Equity (X), as of Mar 25, the value is -2.38. This value is within the healthy range. It has increased from -2.67 (Mar 24) to -2.38, marking an increase of 0.29.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 1.88 (Mar 24) to 1.66, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.64, marking a decrease of 0.22.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 3. It has increased from -6.99 (Mar 24) to 1.12, marking an increase of 8.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -128.14. This value is below the healthy minimum of 3. It has increased from -171.73 (Mar 24) to -128.14, marking an increase of 43.59.
- For Enterprise Value (Cr.), as of Mar 25, the value is 91.12. It has decreased from 107.14 (Mar 24) to 91.12, marking a decrease of 16.02.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 721.44 (Mar 24) to 0.00, marking a decrease of 721.44.
- For EV / EBITDA (X), as of Mar 25, the value is 4,578.83. This value exceeds the healthy maximum of 15. It has increased from -912.86 (Mar 24) to 4,578.83, marking an increase of 5,491.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 245.76 (Mar 24) to 0.00, marking a decrease of 245.76.
- For Price / BV (X), as of Mar 25, the value is -0.47. This value is below the healthy minimum of 1. It has increased from -1.35 (Mar 24) to -0.47, marking an increase of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 250.00 (Mar 24) to 0.00, marking a decrease of 250.00.
- For EarningsYield, as of Mar 25, the value is -0.34. This value is below the healthy minimum of 5. It has decreased from -0.07 (Mar 24) to -0.34, marking a decrease of 0.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tijaria Polypipes Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -6.91% (Industry Average ROCE: 10.4%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 10.62%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -128.14
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 46.06)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | SP-1-2316, RIICO Industries Area, Jaipur Rajasthan 302022 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Alok Jain Tijaria | Managing Director |
| Mr. Vikas Jain Tijaria | Whole Time Director - Marketing |
| Mr. Praveen Jain Tijaria | Whole Time Director - Production |
| Mr. Vineet Jain Tijaria | Whole Time Director - Finance |
| Ms. Khushi Nagrath | Ind. Non-Executive Woman Director |
| Mr. Ashok Kumar | Ind. Non-Executive Director |
| Mrs. Anjali Udhwani | Ind. Non-Executive Woman Director |
| Mrs. Sonu Surana | Ind. Non-Executive Woman Director |
FAQ
What is the intrinsic value of Tijaria Polypipes Ltd?
Tijaria Polypipes Ltd's intrinsic value (as of 29 December 2025) is 21.30 which is 309.62% higher the current market price of 5.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 14.9 Cr. market cap, FY2025-2026 high/low of 12.4/4.52, reserves of ₹-61.79 Cr, and liabilities of 49.08 Cr.
What is the Market Cap of Tijaria Polypipes Ltd?
The Market Cap of Tijaria Polypipes Ltd is 14.9 Cr..
What is the current Stock Price of Tijaria Polypipes Ltd as on 29 December 2025?
The current stock price of Tijaria Polypipes Ltd as on 29 December 2025 is 5.20.
What is the High / Low of Tijaria Polypipes Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tijaria Polypipes Ltd stocks is 12.4/4.52.
What is the Stock P/E of Tijaria Polypipes Ltd?
The Stock P/E of Tijaria Polypipes Ltd is .
What is the Book Value of Tijaria Polypipes Ltd?
The Book Value of Tijaria Polypipes Ltd is 11.6.
What is the Dividend Yield of Tijaria Polypipes Ltd?
The Dividend Yield of Tijaria Polypipes Ltd is 0.00 %.
What is the ROCE of Tijaria Polypipes Ltd?
The ROCE of Tijaria Polypipes Ltd is 5.05 %.
What is the ROE of Tijaria Polypipes Ltd?
The ROE of Tijaria Polypipes Ltd is %.
What is the Face Value of Tijaria Polypipes Ltd?
The Face Value of Tijaria Polypipes Ltd is 10.0.